Michael R Freeman

9PUBLICATIONS
48CO-AUTHORS
Predictive and prognostic markersGenome structure and regulationMedical infection agents (incl. prions)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 10, 2025
Emerin Dysregulation Drives the Very-Small-Nuclear Phenotype and Lineage Plasticity That Associate with a Clinically Aggressive Subtype of Prostate Cancer.

Le Zhang, Pai-Chi Teng, Karen A Cavassani

|Oct 19, 2024
The homeodomain regulates stable DNA binding of prostate cancer target ONECUT2.

Avradip Chatterjee, Brad Gallent, Madhusudhanarao Katiki

|Jun 05, 2024
Profiling phagosome proteins identifies PD-L1 as a fungal-binding receptor.

Kai Li, Avradip Chatterjee, Chen Qian

|Dec 11, 2023
The effects of glycemic index on prostate cancer progression in a xenograft mouse model.

Gloria Cecilia Galván, Everardo Macias, Sergio Sanders

|Nov 14, 2023
Genetic and biological drivers of prostate cancer disparities in Black men.

Jun Gong, Daniel M Kim, Michael R Freeman

Pageof 2